Summary & Overview
HCPCS V5095: Semi-implantable Middle Ear Hearing Prosthesis
HCPCS Level II code V5095 identifies a semi-implantable middle ear hearing prosthesis used in surgical management of conductive or mixed hearing loss. Nationally, this code matters because implantable hearing devices are high-cost, procedure-driven items that affect surgical workflows, device inventory management, and payer coverage policies across commercial and federal programs.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for semi-implantable middle ear prostheses, typical sites of service, and the payer landscape. The publication summarizes what providers and administrators need to know about billing expectations and payer coverage patterns at a national level.
The report also outlines benchmark considerations for device reimbursement, common billing modifiers and service-line implications, and relevant policy and coding notes affecting claim submission. Where input data is incomplete, the publication flags missing fields and directs readers to seek payer-specific policy language or local coverage determinations for definitive guidance.
Billing Code Overview
HCPCS Level II code V5095 denotes a semi-implantable middle ear hearing prosthesis. This device is used to restore or improve auditory function by mechanically transmitting sound to the middle ear structures. The service type is implantable hearing device placement. The typical site of service is hospital outpatient department or ambulatory surgical center, where otologic implant procedures and device programming commonly occur.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with progressive mixed conductive and sensorineural hearing loss, persistent despite hearing aid amplification, undergoes implantation of a semi-implantable middle ear hearing prosthesis (V5095). The typical clinical workflow begins with audiologic evaluation including pure-tone and speech audiometry, tympanometry, and CT imaging of the temporal bones to assess middle ear anatomy. An otologist (otolaryngologist) consult documents medical necessity and discusses risks/benefits. Preoperative clearance and informed consent are completed. In the operating room under general anesthesia, the surgeon performs a transcanal or postauricular approach to expose the ossicular chain and middle ear. The semi-implantable device is positioned with an implanted transducer coupled to the ossicular chain or round window and an external sound processor fitted post-healing. Postoperative care includes brief inpatient observation or same-day discharge, wound checks, device activation and mapping with the audiologist at approximately 4–6 weeks, and routine audiologic follow-up to optimize functional outcomes.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work, time, or complexity substantially exceeds typical for the procedure. |